Physician

Miodrag Velickovic, M.D.

According to 2025 Medicare claims, Miodrag Velickovic, M.D. (NPI: 1619948783) practices neuropsychiatry in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Westchester, NY. This provider's primary affiliated billing organization is MIODRAG VELICKOVIC, M.D. P.C. (NPI: 1750554705; TIN: 131740120) and primary practice location at 10598-4447. Velickovic is affiliated with the CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under the REACH model.

Velickovic's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 549 traditional Medicare patients, billed 47,250 HCPCS/CPT codes, and received $452,380 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,650 prescription claims across 404 beneficiaries totaling $1,026,643 in drug costs, led by Skyclarys (Omaveloxolone). 2021 DME data shows 22 claims. Open Payments data shows 23 records totaling $660. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $968,584 and ending at $1,026,643. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $846 to $289.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	409	41,273	$303,083
2016	467	45,306	$342,098
2017	516	42,656	$349,617
2018	527	41,948	$360,148
2019	576	47,451	$387,501
2020	474	43,568	$362,995
2021	517	47,118	$434,260
2022	523	45,735	$420,112
2023	541	43,732	$416,619
2024	549	47,250	$452,380

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	252	2,255	$968,584
2016	271	2,238	$737,193
2017	350	2,851	$1,181,647
2018	359	3,116	$1,471,099
2019	378	3,080	$1,255,761
2020	351	3,243	$1,112,235
2021	371	3,324	$1,152,589
2022	372	2,800	$951,612
2023	390	2,575	$892,850
2024	404	2,650	$1,026,643

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$382
2016	N/R	N/R	N/R
2017	N/R	12	$428
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	22	$1,978
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	149	149	$193
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	222	440	$153
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	272	532	$109
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	468	1,094	$14
J0585	Injection, onabotulinumtoxina, 1 unit	89	44,427	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Skyclarys	Omaveloxolone	12	360	$387,212
Tetrabenazine	Tetrabenazine	13	390	$237,919
Rytary	Carbidopa/Levodopa	42	2,037	$67,245
Qulipta	Atogepant	29	990	$36,454
Austedo	Deutetrabenazine	11	315	$28,814

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$660	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Miodrag Velickovic, M.D.?

Tedicare shows public-source Medicare data for Miodrag Velickovic, M.D. (NPI 1619948783), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Miodrag Velickovic, M.D. have ACO affiliation data?

Miodrag Velickovic, M.D. is shown with ACO affiliation data for CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Miodrag Velickovic, M.D.?

Miodrag Velickovic, M.D. is linked to MIODRAG VELICKOVIC, M.D. P.C. (billing NPI 1750554705) in the available physician profile data.

Does Miodrag Velickovic, M.D. have Open Payments data?

Miodrag Velickovic, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.